Technology
Robert F. Kennedy Jr. introduces a new initiative to expedite autism diagnoses while addressing challenges in current methodologies.
Technology
Kennedy reinforced his anti-vaccine advocacy during a pivotal speech at a Children’s Health Defense conference, highlighting its significance ahead of upcoming elections.
Finance
The FDA has approved Fayuvi, the first gene therapy for Sanfilippo syndrome, offering hope to affected families and changing treatment dynamics.
Technology
Pennsylvania's measles outbreak has claimed a fourth life, highlighting a growing public health crisis as vaccination rates decline.
Technology
Robert F. Kennedy Jr. is set to speak at an anti-vaccine conference, marking his first major public appearance with the group since joining HHS.
Technology
The FDA's new pilot program aims to expedite the initiation of human testing for drugmakers, responding to industry demands for faster processes.
Technology
Drugmakers are investigating the use of obesity treatments in children as young as six, reflecting a shift in pediatric health approaches.
Finance
GSK has secured global rights to a novel multiple myeloma treatment from China's Chimagen Biosciences, enhancing its pipeline with a $750 million investment.
Technology
Recent documents highlight significant issues with Medicare's prior-authorization pilot, raising questions about its effectiveness and future rollout.
Technology
Businesses can now apply for NIH funding, broadening access to vital resources for health and science advancements.
Finance
Trutakna effectively stabilized kidney function and reduced risks in patients with IgA nephropathy, prompting Vera to seek full FDA approval.
Finance
A recent study shows exercise helps maintain heart health in astronauts during long-duration space missions, vital for future Mars expeditions.
Technology
U.S. health officials announce the end of a historic cyclospora outbreak, yet its origin remains uncertain despite extensive investigations.
Finance
Medicaid's new tiered system for assessing medical frailty aims to streamline exemptions for the seriously ill, but raises ongoing concerns.
Finance
Novartis investors heighten scrutiny following drug trial failures and the looming expiration of key biologics patents, impacting market confidence.